From Urgency To Understanding
The Next Phase of Pharma Serialisation by Ankhero Insights In 2019, serialisation decisions were made in a state of urgency.In 2026, those same decisions are being revisited in a state of understanding. 2019: A Reactive Phase In 2019, pharmaceutical companies faced a hard deadline — and an even harder reality. Regulations were coming into force. […]
Common Sense vs. Nonsense: A Teardown of “Artificial Expert Intelligence”
Common Sense vs. Nonsense: A Teardown of “Artificial Expert Intelligence” By JJS Ahdan I recently read an article by Shabir Dahod titled “Could Artificial Expert Intelligence Fix Pharma’s Supply Chain Gaps?”. I was genuinely interested to read his perspective on the role of AI. However, I fundamentally disagree with Shabir — not just on the […]
Is TraceLink’s Validation Tool Creating More Risk Than Value?
For companies working in regulated environments, validation is non-negotiable. What happens when the tool you’re relying on starts becoming part of the problem. Delivering meaningful value, or simply the illusion of control? Feedback from users often highlights that TraceLink’s validations are superficial, designed more to satisfy system checks than to reflect the true complexity of […]
Why FMD Alerts Are More About Systems Than Counterfeits!
National Bottlenecks If you’re resolving alerts without involving your NMVO, or worse, relying solely on EMVO – you’re working uphill. When the EU’s Falsified Medicines Directive went live, it promised a bold new standard: protect patients using real-time verification and serialisation across a harmonised European framework. Years later, the infrastructure largely works. But the majority […]
Points of View… Is Tracelink a sinking ship?
Are Pfizer leaving them? Seems likely from the attached job posting. A bold move, for sure, but one can only assume there is confidence that change is necessary to leave yesterdays technology constraints, and embrace tomorrows opportunities. OPUS is delayed 3 years! Should OPUS be a free upgrade to all existing customers? Will it be […]